These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15024968)

  • 1. Congenital syndromes and leukemia: clues to pathogenesis.
    Izraeli S
    Rev Clin Exp Hematol; 2003 Sep; 7(3):246-60. PubMed ID: 15024968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis.
    Seif AE
    Cancer Genet; 2011 May; 204(5):227-44. PubMed ID: 21665176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of erythroid and megakaryocytic differentiation by a leukemia-associated and t(9;9)-derived fusion gene product, SET/TAF-Ibeta-CAN/Nup214.
    Saito S; Nouno K; Shimizu R; Yamamoto M; Nagata K
    J Cell Physiol; 2008 Feb; 214(2):322-33. PubMed ID: 17620317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converging pathways in leukemogenesis and stem cell self-renewal.
    Moore MA
    Exp Hematol; 2005 Jul; 33(7):719-37. PubMed ID: 15963848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis.
    Hirabayashi Y; Yoon BI; Tsuboi I; Huo Y; Kodama Y; Kanno J; Ott T; Trosko JE; Inoue T
    Exp Biol Med (Maywood); 2007 May; 232(5):700-12. PubMed ID: 17463168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia.
    Catalina P; Bueno C; Montes R; Nieto A; Ligero G; Sanchez L; Jara M; Rasillo A; Orfao A; Cigudosa J; Hovatta O; Greaves M; Menendez P
    Leuk Res; 2009 Jul; 33(7):980-90. PubMed ID: 18930318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: chromosomal aneuploidy in leukemia--lessons from down syndrome.
    Izraeli S
    Hematol Oncol; 2006 Mar; 24(1):3-6. PubMed ID: 16270377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Down's syndrome in a child with coexistent congenital leukemia and heart disease].
    He L; Gao HX; Tang JM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):384. PubMed ID: 17052397
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.
    Shimizu R; Kobayashi E; Engel JD; Yamamoto M
    Genes Cells; 2009 Sep; 14(9):1119-31. PubMed ID: 19682090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
    Tsuzuki S; Seto M; Greaves M; Enver T
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
    Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
    Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?
    Göhring G; Karow A; Steinemann D; Wilkens L; Lichter P; Zeidler C; Niemeyer C; Welte K; Schlegelberger B
    Ann Hematol; 2007 Oct; 86(10):733-9. PubMed ID: 17653548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in normal and malignant hematopoiesis.
    Garzon R; Croce CM
    Curr Opin Hematol; 2008 Jul; 15(4):352-8. PubMed ID: 18536574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of erythroid, megakaryocyte and myeloid hematopoietic support function with neutralizing antibodies against IL-4 and TGFbeta1 in long-term bone marrow cultures infected with LP-BM5 murine leukemia virus.
    Tse KF; Inayat MS; Morrow JK; Hughes NK; Oakley OR; Gallicchio VS
    Virus Res; 2005 Oct; 113(1):1-15. PubMed ID: 15869820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome, drug metabolism and chromosome 21.
    Taub JW; Ge Y
    Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
    Vyas P; Roberts I
    Early Hum Dev; 2006 Dec; 82(12):767-73. PubMed ID: 17064858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental smoking and childhood leukemia.
    Chang JS
    Methods Mol Biol; 2009; 472():103-37. PubMed ID: 19107431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.